These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10532694)

  • 21. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW; Sacks FM
    J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes mellitus.
    Howard BV; Abbott WG; Egusa G; Taskinen MR
    Am Heart J; 1987 Feb; 113(2 Pt 2):522-6. PubMed ID: 3544765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glucocorticoid-induced hypertiglyceridemia: effects of cortisone acetate on triglyceride secretion rates and post-heparin lipolytic activity in rabbits (author's transl)].
    Mibayashi Y
    Nihon Naibunpi Gakkai Zasshi; 1978 Mar; 54(3):203-18. PubMed ID: 206474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
    Taskinen MR; Packard CJ; Shepherd J
    Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipase.
    Homma Y; Moriguchi EH; Sakane H; Ozawa H; Nakamura H; Goto Y
    Atherosclerosis; 1991 Jun; 88(2-3):175-81. PubMed ID: 1892484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters.
    Lewis GF; Naples M; Uffelman K; Leung N; Szeto L; Adeli K
    Endocrinology; 2004 Nov; 145(11):5006-12. PubMed ID: 15271878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slower catabolism of apo B48 than of apo B100 in triglyceride-rich lipoproteins during heparin infusions in type 5 hyperlipoproteinemic subjects.
    Nestel P; Billington T
    Metabolism; 1987 Feb; 36(2):172-5. PubMed ID: 3807788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
    Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
    Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy.
    Taskinen MR; Beltz WF; Harper I; Fields RM; Schonfeld G; Grundy SM; Howard BV
    Diabetes; 1986 Nov; 35(11):1268-77. PubMed ID: 3530855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
    Brinton EA; Eisenberg S; Breslow JL
    J Clin Invest; 1991 Feb; 87(2):536-44. PubMed ID: 1899429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of lipoprotein lipolysis by polyarginine and evaluation of the mechanism of its interaction with lipoprotein lipase].
    Klimov AN; Serrano DS; Kliueva NN; Soliternova IB; Nikul'cheva NG
    Biokhimiia; 1985 May; 50(5):804-13. PubMed ID: 4005323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism.
    Packard CJ; Shepherd J; Lindsay GM; Gaw A; Taskinen MR
    J Clin Endocrinol Metab; 1993 May; 76(5):1209-16. PubMed ID: 8496312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-heparin triacylglycerol lipases in ovine plasma.
    Tume RK; Thornton RF; Johnson GW
    Aust J Biol Sci; 1988; 41(2):215-21. PubMed ID: 3270309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
    Jansen H; Hop W; van Tol A; Bruschke AV; Birkenhäger JC
    Atherosclerosis; 1994 May; 107(1):45-54. PubMed ID: 7945558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.